21:37 02/07/2015 Arena Pharmaceuticals Given Consensus Rating of "Hold" by Brokerages ...
Arena Pharmaceuticals Given Consensus Rating of "Hold" by Brokerages ...
Dakota Financial News - Jul 2, 2015
Arena Pharmaceuticals logo Arena Pharmaceuticals (NASDAQ:ARNA) has been given a consensus rating of “Hold” by the seven analysts that are currently covering the company, ARN reports. Two analysts have rated the stock with a sell recommendation, ...

11:07 02/07/2015 Biotech Stocks getting no love - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Biotech Stocks getting no love - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Wall Street Observer - Jul 2, 2015
Mr. Hoffman is expected to remain in his current role at Arena until July 10, 2015. “Robert has been a valuable member of our management team and, on behalf of myself and the company, I thank him for his years of leadership and service to Arena,” said ...

7:33 02/07/2015 Analyst Price Target Update on Arena Pharmaceuticals, Inc.
Analyst Price Target Update on Arena Pharmaceuticals, Inc.
Insider Trading Report - Jul 2, 2015
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): The mean estimate for the short term price target for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stands at $5.63 according to 4 Analysts. The higher price target estimate for the stock has been calculated at $8 ...

11:29 01/07/2015 Fall in love with these 3 Biotech stocks - Arena Pharmaceuticals, Inc. (NASDAQ ...
Fall in love with these 3 Biotech stocks - Arena Pharmaceuticals, Inc. (NASDAQ ...
Wall Street Observer - Jul 1, 2015
Ms. Bielasz joined Arena in 2001 and is responsible for managing all accounting activities. Prior to joining Arena, Ms. Bielasz served as the controller of both public and private companies and began her career at KPMG LLP.
Healthcare Sector Update: KERX, IDRA, ARNA, CLDX - Wsnews4investors (press release) (blog)

17:52 30/06/2015 Momentum Stock in Focus - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Momentum Stock in Focus - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Enterprise Leader - Jun 30, 2015
According to Zacks, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has been given a high momentum style score. The score calculation is based on a number of factors indicating that the stock might be at a favorable level to enter a position based on the ...
Company Shares of Arena Pharmaceuticals, Inc. Drops by -0.68% - Insider Trading Report
Healthcare Sector Movers: Halozyme Therapeutics, Inc. (HALO), Arena ... - WallStreet Scope

11:21 29/06/2015 Biotech Stocks with Optimistic Trend - Arena Pharmaceuticals, Inc. (NASDAQ ...
Biotech Stocks with Optimistic Trend - Arena Pharmaceuticals, Inc. (NASDAQ ...
Wall Street Observer - Jun 29, 2015
Mr. Hoffman is expected to remain in his current role at Arena until July 10, 2015. “Robert has been a valuable member of our management team and, on behalf of myself and the company, I thank him for his years of leadership and service to Arena,” said ...

5:41 25/06/2015 Arena Pharmaceuticals, Inc. Short Interest Update
Arena Pharmaceuticals, Inc. Short Interest Update
Insider Trading Report - Jun 25, 2015
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has seen a shortfall of 260,771 shares or 0.8% in the short interest. The remaining shorts are 12.8% of the total floated shares.

12:26 23/06/2015 Zacks Short Term Rating on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Zacks Short Term Rating on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Insider Trading Report - Jun 23, 2015
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is a hold, according to the latest average broker rating of 2.5. The number of analysts in this rating is 6. Research Analysts at Zacks has the shares a rating of 3, which implies that the firms recommendation ...

14:30 22/06/2015 Stock Insights on Arena Pharmaceuticals Inc (NASDAQ:ARNA)
Stock Insights on Arena Pharmaceuticals Inc (NASDAQ:ARNA)
Markets Wired - Jun 22, 2015
[PRNewswire] Arena Pharmaceuticals Inc (NASDAQ:ARNA)(TREND ANALYSIS) announced that Robert E. Hoffman, Senior Vice President, Finance and Chief Financial Officer, has decided to leave the company after nearly 18 years of service to pursue ...
3 Biotech Stocks Are Getting Crushed – Arena Pharmaceuticals, Inc. (NASDAQ ... - Wall Street Observer
Stocks Plunging - Arena Pharmaceuticals (ARNA), Paragon Offshore (PGN ... - Investor Wired

20:35 17/06/2015 Can Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Surprise Analysts this Quarter?
Can Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Surprise Analysts this Quarter?
Investor Newswire - Jun 17, 2015
In the most recent quarter, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported an earnings surprise of 28.57% when the firm last announced their results for the period ending on 2015-03-31.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Price Target Update - OTC Outlook